Cloning and expression of a rat D2 dopamine receptor cDNA JR Bunzow, HHMV Tol, DK Grandy, P Albert, J Salon, MD Christie, ... Nature 336 (6201), 783-787, 1988 | 1549 | 1988 |
Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer M Canals, D Marcellino, F Fanelli, F Ciruela, P De Benedetti, ... Journal of Biological Chemistry 278 (47), 46741-46749, 2003 | 567 | 2003 |
Modulation of D2R-NR2B interactions in response to cocaine XY Liu, XP Chu, LM Mao, M Wang, HX Lan, MH Li, GC Zhang, ... Neuron 52 (5), 897-909, 2006 | 312 | 2006 |
Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type AJ Eshleman, M Carmolli, M Cumbay, CR Martens, KA Neve, A Janowsky Journal of Pharmacology and Experimental Therapeutics 289 (2), 877-885, 1999 | 290 | 1999 |
The dopamine receptors K Neve Springer Science & Business Media, 2009 | 273* | 2009 |
Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. KA Neve, BA Cox, RA Henningsen, A Spanoyannis, RL Neve Molecular pharmacology 39 (6), 733-739, 1991 | 258 | 1991 |
Dopamine and extinction: a convergence of theory with fear and reward circuitry AD Abraham, KA Neve, KM Lattal Neurobiology of learning and memory 108, 65-77, 2014 | 247 | 2014 |
Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. PR Albert, KA Neve, JR Bunzow, O Civelli Journal of Biological Chemistry 265 (4), 2098-2104, 1990 | 223 | 1990 |
Release of dopamine via the human transporter. AJ Eshleman, RA Henningsen, KA Neve, A Janowsky Molecular pharmacology 45 (2), 312-316, 1994 | 210 | 1994 |
Sensitization of adenylate cyclase by Gαi/o-coupled receptors VJ Watts, KA Neve Pharmacology & therapeutics 106 (3), 405-421, 2005 | 172 | 2005 |
Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors BA Cox, RA Henningsen, A Spanoyannis, RL Neve, KA Neve Journal of neurochemistry 59 (2), 627-635, 1992 | 170 | 1992 |
DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3 DL McPhie, R Coopersmith, A Hines-Peralta, Y Chen, KJ Ivins, SP Manly, ... Journal of Neuroscience 23 (17), 6914-6927, 2003 | 168 | 2003 |
Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity KA Neve, MR Kozlowski, JF Marshall Brain research 244 (1), 33-44, 1982 | 164 | 1982 |
Molecular cloning and expression of the rat beta 1-adrenergic receptor gene. CA Machida, JR Bunzow, RP Searles, H Van Tol, B Tester, KA Neve, ... Journal of Biological Chemistry 265 (22), 12960-12965, 1990 | 149 | 1990 |
Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. VJ Watts, KA Neve Molecular Pharmacology 50 (4), 966-976, 1996 | 133 | 1996 |
Regulation of dopamine D2 receptors by sodium and pH. KA Neve Molecular pharmacology 39 (4), 570-578, 1991 | 133 | 1991 |
Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation. KA Neve, RL Neve, S Fidel, A Janowsky, GA Higgins Proceedings of the National Academy of Sciences 88 (7), 2802-2806, 1991 | 133 | 1991 |
D2 dopamine receptors stimulate mitogenesis through pertussis toxin‐sensitive G proteins and Ras‐involved ERK and SAP/JNK pathways in rat C6‐D2L glioma cells Y Luo, GC Kokkonen, X Wang, KA Neve, GS Roth Journal of neurochemistry 71 (3), 980-990, 1998 | 130 | 1998 |
Computer-assisted video analysis of [3H] spiroperidol binding autoradiographs CA Altar, RJ Walter Jr, KA Neve, JF Marshall Journal of neuroscience methods 10 (3), 173-188, 1984 | 120 | 1984 |
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors VJ Watts, RB Mailman, CP Lawler, KA Neve, DE Nichols Psychopharmacology 118, 401-409, 1995 | 119 | 1995 |